Concepedia

Matthew A. Naylor

MA

Statistics

Publications

35

Citations

1.3K

H-Index

20

Active since

1947

Affiliations

Mount Vernon Hospital(Current)

University of Manchester

Devon History Society

University of Exeter

Rhodes University

Matthew A. Naylor is an author at Mount Vernon Hospital specializing in pharmacology, medicinal chemistry, and medicine.

Publications per year

1947–2012

35

Publications

35

ZD6126: a novel vascular-targeting agent that causes selective destruction of tumor vasculature.

Peter D. Davis, Graeme J. Dougherty, David C. Blakey et al. · PubMed · 2002 · 231 citations

, , +17

Pyrolysis of Polytetrafluoroethylene

Ernest E. Lewis, Matthew A. Naylor · Journal of the American Chemical Society · 1947 · 172 citations

, , +5

Synthesis and evaluation of .alpha.-[[(2-haloethyl)amino]methyl]-2-nitro-1H-imidazole-1-ethanols as prodrugs of .alpha.-[(1-aziridinyl)methyl]-2-nitro-1H-imidazole-1-ethanol (RSU-1069) and its analogs which are radiosensitizers and bioreductively activated cytotoxins

Terence C. Jenkins, Matthew A. Naylor, Peter O’Neill et al. · Journal of Medicinal Chemistry · 1990 · 82 citations

, , +7

Indolequinone Antitumor Agents:  Reductive Activation and Elimination from (5-Methoxy-1-methyl-4,7-dioxoindol-3-yl)methyl Derivatives and Hypoxia-Selective Cytotoxicity in Vitro

Matthew A. Naylor, Elizabeth Swann, Steven A. Everett et al. · Journal of Medicinal Chemistry · 1998 · 69 citations

, , +13

Bioreductive Activation of a Series of Indolequinones by Human DT-Diaphorase:  Structure−Activity Relationships

Roger M. Phillips, Matthew A. Naylor, Mohammed Jaffar et al. · Journal of Medicinal Chemistry · 1999 · 60 citations

, , +15

1–5 of 35